Active ingredientSertaconazole NitrateCat. No. P-S035-001CAS 99592-39-9Family · Pharmaceutical analytical standards
Sertaconazole
An imidazole antifungal with a benzothiophene ring, developed in Spain and approved in the United States in 2003 as a cream for athlete's foot; it is also available as vaginal tablets. This family brings together the active ingredient, pharmacopoeial impurities and labelled standards.
Did you know?Its benzothiophene ring is the sulphur analogue of the indole ring of tryptophan: by mimicking it, the molecule slips into the fungal membrane and opens pores in it.
Go to the active ingredient →Active ingredientSertaconazole NitrateCat. No. P-S035-001CAS 99592-39-9
Pharmacopoeial impuritySertaconazole EP Impurity BCat. No. P-S035-002CAS 17512-61-7
Pharmacopoeial impuritySertaconazole EP Impurity CCat. No. P-S035-003CAS 142181-53-1
Isotopically labelledSertaconazole-d6Cat. No. P-S035-004CAS 1330261-47-6No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceSertaconazole nitrate CRSEDQM code S0460000Family SertaconazoleNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.